Table 6.
Pain during chronic inflammation.
Drug | Dose | Route | Reference |
---|---|---|---|
CFA inflammation | |||
Agonist | |||
NMDA | 0.01–0.5 mM, 20 μl | i.pl. | Du et al., 2003 |
Kainate | 1 mM, 20 μl | i.pl. | Du et al., 2006 |
Antagonist | |||
DON | 0.8–800 mM (0.02–20 μmol/25 μl) | i.pl. | Miller et al., 2010b |
MK 801 | 0.5 mM, 20 μl | i.pl. | Du et al., 2003 |
CNQX | 0.1 mM, 20 μl | i.pl. | Du et al., 2006 |
MK 801 | 10 nM (1 pmol/100 μl) | i.pl. | Leem et al., 2001 |
MPEP | 10–30 mM (100–300 nmol/10 μl) | i.pl. | Walker et al., 2001 |
Formalin | |||
Agonist | |||
Glutamate, NMDA, AMPA, or kainate | 20 mM; (1 μmol/50 μl) | i.pl. | Aumeerally et al., 2004 |